Free Trial

Over $66B Corporate Issuance This Week

PIPELINE
$27.75B Priced Thursday, $66.25B for the week - over $50B estimated for the week - driven in large part by Abbvie's $15B 7pt and Cisco's $13.5B 7pt issuance this week.
  • Date $MM Issuer (Priced *, Launch #)
  • 2/22 $15B *Abbvie** $2.25B 3Y +35, $2.5B 5Y +50, $2B 7Y +60, $3B 10Y +75, $750M 20Y +75, $3B 30Y +95, $1.5B 40Y +105
  • 2/22 $3.1B *Panama $1.1B 7Y 7.5%, $1.25B 13Y 8%, $750M 33Y 8.25%
  • 2/22 $2B *Caterpillar $800M 2Y +35, $600M 2Y SOFR+46, $600M 5Y +55
  • 2/22 $2B *Federal Rep of Germany (KFW) 10Y +51
  • 2/22 $2B *BNG Bank 3Y SOFR +32
  • 2/22 $1.7B *Exelon $650M 5Y +87.5, $650M 10Y +115, $400M 29Y +130
  • 2/22 $1.25B *Royal Caribbean 8NC3 6.25%
  • 2/22 $700M *Northern States WNG 30Y +97
  • **Abbvie held investor calls Wednesday after filing funding offer to fund Immunogen deal.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.